Melanoma March has officially launched
5 February 2015
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
The launch event held at Tonic House in Melbourne’s CBD revealed plans for the new funding. There will be 23 marches that are happening around Australia, with the first march kicking off in Melbourne on the 22nd February.
Professor Graham Mann, Research Director at MIA, explained how the Melanoma March campaign provides critical funding for our expert clinicians to get one step closer to finding a cure. He revealed the beneficiary of the 2015 initiative will be the next phase of the Melanoma Genome Project.
“Monies raised from last year’s Melanoma March campaign contributed to the world-first PD-1 Brain Metastases Trial - that is currently underway,” he said.
“Half of all patients diagnosed with stage 4 melanoma will develop brain metastases at some point during their illness. Until now, treatment has been unavailable and as such the clinicians at Melanoma Institute Australia are committed to developing new treatment options that provide potential hope to patients with brain metastases and could prove to be a significant step in finding a cure.
“Funds raised from the 2015 Melanoma March campaign will enable Melanoma Institute Australia and melanoma research centres around the nation to work together to launch a study which hopes to enable melanoma cells to be isolated, banked, distributed and tested against new treatments. This approach is a powerful way to capitalise on new knowledge from gene and immunity analysis that is showing where melanoma is vulnerable to attack.
Known as ‘Australia’s national cancer’, Australia has the highest incidence of melanoma in the world with over 12,500 new cases diagnosed each year, equating to one person dying every six hours from melanoma in Australia. Sadly, melanoma kills more young Australians (15-39 year-olds) than any other single cancer, proving why continual funding for research is key in addressing this devastating illness.
The Melbourne launch was also attended by former AFL icon and melanoma survivor, Tim McGrath as well as award winning musician Bob Corbett and channel Ten news presenter Brad McEwen.
To see where your local march is and how you can get involved to help us raise $1 million for melanoma research click here.
Melanoma research gets a funding boost from NHMRC
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
Challenges in melanoma clinical research
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Global Melanoma Research Report
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
Announcement from Melanoma Institute Australia
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Nine practice points from the new melanoma guidelines
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Melanoma under 40
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Don't let sunburn be your summer holiday souvenir
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Using clinical features to identify patients at high risk for melanoma
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Congratulations to Professor Georgina Long
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
Uniting our global researchers for melanoma
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care go digital
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Awards and honours for our talented researchers
Congratulations are in order for two of our talented researchers.
5 Minutes With Prof Richard Scolyer
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Research spotlight: High Risk Clinic
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
Learning from the best in the world
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
Uniting the world for a cure
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
A Day in the Life of... Michelle Peranec
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Wildfire Award helps ignite new melanoma research
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Opinion: Fighting the Resistance
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
5 Minutes With A/Prof Jennifer Wargo
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.